Notable 52-Week Highs and Lows of the Day 09/07: (GE) (PPHM) (ULTA) High; (ADNC) (DDMG) (ENVI) Low
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/1/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Wall Street ends higher as Amazon soothes AI jitters
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Digital Domain (DDMG) Says Interim COO Making Decisions on CEO Departure
September 7, 2012 1:27 PM EDTDigital Domain Media Group, Inc. (NYSE: DDMG) clarified that following the departure of its Chairman and CEO, the Board of Directors of the Company and its Interim Chief Operating Officer are making decisions on behalf of the Company and that the Company is weighing... More
Peregrine Pharma (PPHM) Reports Statistically Significant Data from Bavituximab Phase IIb
September 7, 2012 12:53 PM EDTPeregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), today announced that interim results were presented from its 121 patient randomized, double-blind, placebo-controlled Phase IIb trial in patients with refractory non-small cell lung cancer (NSCLC).
The blinded study evaluated two dose levels of bavituximab (bavituximab-containing arms) given with docetaxel versus docetaxel... More
General Electric (GE) Declares $0.17 Quarterly Dividend; 3.2% Yield
September 7, 2012 12:46 PM EDTGeneral Electric (NYSE: GE) declared a quarterly dividend of $0.17 per share, or $0.68 annualized.
The dividend will be payable on October 25, 2012, to stockholders of record on September 24, 2012, with an ex-dividend date of September 20, 2012.
The annual yield on the dividend is 3.2 percent.... More
Digital Domain (DDMG) Initiates Strategic Realignment; CEO Textor Resigns, Will Cease Port St. Lucie Operations
September 7, 2012 10:50 AM EDTDigital Domain Media Group, Inc. (NYSE: DDMG) has initiated a strategic realignment that will enable it to focus its resources on its core business, Digital Domain Productions, Inc., a company focused on creating digital visual effects, CG animation and digital production for the entertainment and advertising industries. As a key part of this strategic realignment, DDMG has begun the cessation of its Port St. Lucie operations by reducing virtually its entire Port St. Lucie workforce,... More
Audience (ADNC) Says Processor IP Might Not Be Used by Apple (AAPL) in iPhone 5; Boosts Q3 Outlook
September 6, 2012 4:27 PM EDTAudience, Inc. (Nasdaq: ADNC) provided an update on the prospects for use of its processor intellectual property (processor IP) in the next generation mobile phone release of a large OEM customer. Additionally, Audience provided an update to its business outlook for the third quarter of 2012.
Product Transition
Audience sells processors and licenses its processor IP to Apple Inc. (Nasdaq: AAPL) and certain of its subsidiaries (collectively, OEM) for inclusion in the OEM's mobile phones pursuant to a Master Development and Supply Agreement (MDSA).... More
Envivio (ENVI) Posts Q2 Loss of 13c/Share; Guides Q3 Loss Expectations Wider than Views
September 6, 2012 4:12 PM EDTEnvivio (NASDAQ: ENVI) reported Q2 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $10.8 million versus the consensus estimate of $10.66 million.
Envivio sees Q3 2013 EPS of $-0.16--0.12, versus the consensus of $-0.09. Envivio sees Q3 2013 revenue of... More
Sturm, Ruger (RGR) Pops on Strong Smith & Wesson Numbers
September 6, 2012 4:12 PM EDTSturm, Ruger & Co. Inc. (NYSE: RGR) is higher after-hours Thursday following strong results and guidance from peer Smith & Wesson Holding Corp. (NASDAQ: SWHC).
Smith & Wesson reported Q1 EPS of $0.28, $0.10 better than the analyst estimate of $0.18. Revenue for the... More
Smith & Wesson Holding Corp. (SWHC) Tops Q1 EPS by 10c; Raises Outlook
September 6, 2012 4:07 PM EDTSmith & Wesson Holding Corp. (NASDAQ: SWHC) reported Q1 EPS of $0.28, $0.10 better than the analyst estimate of $0.18. Revenue for the quarter came in at $136 million versus the consensus estimate of $128.74 million.
Smith & Wesson Holding Corp. sees Q2 2013 EPS of $0.19-0.21, versus the consensus of $0.13.... More
Ulta Salon (ULTA) Tops Q2 EPS by 3c; Issues Q3 Outlook
September 6, 2012 4:01 PM EDTUlta Salon (NASDAQ: ULTA) reported Q2 EPS of $0.54, $0.03 better than the analyst estimate of $0.51. Revenue for the quarter came in at $481.7 million versus the consensus estimate of $473.8 million.
Ulta Salon sees Q3 2012 EPS of $0.54-0.56, versus the consensus of $0.54. Ulta Salon sees Q3 2012... More
